Integra LifeSciences Holdings PE Ratio 2010-2023 | IART
Current and historical p/e ratio for Integra LifeSciences Holdings (IART) from 2010 to 2023. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Integra LifeSciences Holdings PE ratio as of April 24, 2024 is 9.48.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| Integra LifeSciences Holdings PE Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Net EPS | PE Ratio |
| 2024-04-24 | 29.38 | 35.40 | |
| 2023-12-31 | 43.55 | $0.83 | 52.47 |
| 2023-09-30 | 38.19 | $1.21 | 31.56 |
| 2023-06-30 | 41.13 | $1.57 | 26.20 |
| 2023-03-31 | 57.41 | $2.06 | 27.87 |
| 2022-12-31 | 56.07 | $2.16 | 25.96 |
| 2022-09-30 | 42.36 | $2.06 | 20.56 |
| 2022-06-30 | 54.03 | $1.97 | 27.43 |
| 2022-03-31 | 64.26 | $1.84 | 34.92 |
| 2021-12-31 | 66.99 | $1.98 | 33.83 |
| 2021-09-30 | 68.48 | $2.54 | 26.96 |
| 2021-06-30 | 68.24 | $2.41 | 28.32 |
| 2021-03-31 | 69.09 | $2.00 | 34.55 |
| 2020-12-31 | 64.92 | $1.58 | 41.09 |
| 2020-09-30 | 47.22 | $0.67 | 70.48 |
| 2020-06-30 | 46.99 | $-0.03 | 0.00 |
| 2020-03-31 | 44.67 | $0.31 | 144.10 |
| 2019-12-31 | 58.28 | $0.58 | 100.48 |
| 2019-09-30 | 60.07 | $0.69 | 87.06 |
| 2019-06-30 | 55.85 | $1.16 | 48.15 |
| 2019-03-31 | 55.72 | $0.96 | 58.04 |
| 2018-12-31 | 45.10 | $0.72 | 62.64 |
| 2018-09-30 | 65.87 | $0.99 | 66.54 |
| 2018-06-30 | 64.41 | $0.88 | 73.19 |
| 2018-03-31 | 55.34 | $0.88 | 62.89 |
| 2017-12-31 | 47.86 | $0.82 | 58.37 |
| 2017-09-30 | 50.48 | $0.61 | 82.75 |
| 2017-06-30 | 54.51 | $0.82 | 66.48 |
| 2017-03-31 | 42.13 | $0.84 | 50.15 |
| 2016-12-31 | 42.90 | $0.92 | 46.88 |
| 2016-09-30 | 41.28 | $0.76 | 54.31 |
| 2016-06-30 | 39.89 | $0.06 | 664.83 |
| 2016-03-31 | 33.68 | $-0.03 | 0.00 |
| 2015-12-31 | 33.89 | $-0.06 | 0.00 |
| 2015-09-30 | 29.78 | $0.01 | 2978.00 |
| 2015-06-30 | 30.59 | $0.61 | 50.15 |
| 2015-03-31 | 28.00 | $0.61 | 45.89 |
| 2014-12-31 | 24.63 | $0.52 | 47.36 |
| 2014-09-30 | 22.54 | $0.46 | 49.00 |
| 2014-06-30 | 21.37 | $-0.20 | 0.00 |
| 2014-03-31 | 20.88 | $-0.22 | 0.00 |
| 2013-12-31 | 21.67 | $-0.33 | 0.00 |
| 2013-09-30 | 18.28 | $-0.30 | 0.00 |
| 2013-06-30 | 16.63 | $0.45 | 37.38 |
| 2013-03-31 | 17.71 | $0.54 | 33.11 |
| 2012-12-31 | 17.70 | $0.73 | 24.41 |
| 2012-09-30 | 18.66 | $0.58 | 32.46 |
| 2012-06-30 | 16.88 | $0.54 | 31.27 |
| 2012-03-31 | 15.75 | $0.40 | 39.38 |
| 2011-12-31 | 14.00 | $0.48 | 29.47 |
| 2011-09-30 | 16.24 | $0.71 | 22.88 |
| 2011-06-30 | 21.71 | $0.79 | 27.48 |
| 2011-03-31 | 21.53 | $1.03 | 20.91 |
| 2010-12-31 | 21.48 | $1.09 | 19.71 |
| 2010-09-30 | 17.92 | $1.04 | 17.23 |
| 2010-06-30 | 16.80 | $1.01 | 16.64 |
| 2010-03-31 | 19.90 | $0.95 | 20.95 |
| 2009-12-31 | 16.74 | $0.86 | 19.47 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $2.309B | $1.542B |
| Integra LifeSciences is one of the world leaders in regenerative medicine. The company develops, manufactures and markets cost-effective surgical implants and medical instruments. The company now manufactures and sells products in the following two global reportable business segments: Codman Specialty Surgical (CSS) and Orthopedics and Tissue Technologies (OTT). The CSS business offers global, market-leading technologies, brands and instrumentation. The global commercial network includes clinical specialists, a large direct global sales force and strategic partnerships and distributors that serve hospitals, integrated health networks, group purchasing organizations, clinicians, surgery centers and health care providers in North America, South America, Europe, Asia Pacific, Middle East and Africa. The Tissue Technologies segment includes wound reconstruction and repair products, bone grafts and nerve and tendon repair products. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $219.329B | 26.67 |
| Intuitive Surgical (ISRG) | United States | $133.752B | 80.57 |
| DexCom (DXCM) | United States | $53.067B | 88.74 |
| Edwards Lifesciences (EW) | United States | $52.819B | 34.96 |
| IQVIA Holdings (IQV) | United States | $43.310B | 25.69 |
| IDEXX Laboratories (IDXX) | United States | $41.012B | 49.04 |
| Alcon (ALC) | Switzerland | $39.823B | 29.37 |
| STERIS (STE) | Ireland | $20.355B | 24.09 |
| Waters (WAT) | United States | $18.582B | 26.66 |
| Hologic (HOLX) | United States | $18.119B | 20.00 |
| SONOVA HOLDING (SONVY) | Switzerland | $16.651B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $12.605B | 15.56 |
| ShockWave Medical (SWAV) | United States | $12.286B | 84.89 |
| Sysmex ADR (SSMXY) | Japan | $10.120B | 31.74 |
| Teleflex (TFX) | United States | $9.944B | 15.61 |
| Penumbra (PEN) | United States | $7.961B | 98.42 |
| Masimo (MASI) | United States | $7.246B | 40.64 |
| Globus Medical (GMED) | United States | $6.941B | 22.00 |
| Glaukos (GKOS) | United States | $5.074B | 0.00 |
| Integer Holdings (ITGR) | United States | $3.950B | 25.25 |
| LivaNova (LIVN) | United Kingdom | $2.969B | 19.58 |
| TransMedics (TMDX) | United States | $2.964B | 0.00 |
| PROCEPT BioRobotics (PRCT) | United States | $2.763B | 0.00 |
| Elekta AB (EKTAY) | Sweden | $2.704B | 18.55 |
| Nihon Kohden (NHNKY) | Japan | $2.379B | 20.12 |
| Tandem Diabetes Care (TNDM) | United States | $2.258B | 0.00 |
| Inari Medical (NARI) | United States | $2.151B | 371.10 |
| RxSight (RXST) | United States | $2.031B | 0.00 |
| Alphatec Holdings (ATEC) | United States | $1.784B | 0.00 |
| Veracyte (VCYT) | United States | $1.489B | 0.00 |
| OPKO Health (OPK) | United States | $0.871B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.867B | 16.03 |
| Artivion (AORT) | United States | $0.856B | 98.95 |
| Paragon 28 (FNA) | United States | $0.833B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.729B | 0.00 |
| Silk Road Medical (SILK) | United States | $0.692B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.671B | 0.00 |
| SiBone (SIBN) | United States | $0.627B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.575B | 19.53 |
| IRadimed (IRMD) | United States | $0.531B | 30.81 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.495B | 0.00 |
| Nevro (NVRO) | United States | $0.469B | 0.00 |
| NeuroPace (NPCE) | United States | $0.402B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.394B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $0.379B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.346B | 11.66 |
| CVRx (CVRX) | United States | $0.309B | 0.00 |
| AxoGen (AXGN) | United States | $0.305B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.279B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.263B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.242B | 0.00 |
| Accuray (ARAY) | United States | $0.220B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.190B | 10.26 |
| Atossa Genetics (ATOS) | United States | $0.187B | 0.00 |
| 908 Devices (MASS) | United States | $0.183B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.174B | 0.00 |
| Inogen (INGN) | United States | $0.162B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.149B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.142B | 0.00 |
| Neuronetics (STIM) | United States | $0.116B | 0.00 |
| Yubo Biotech (YBGJ) | China | $0.112B | 0.00 |
| Envoy Medical (COCH) | United States | $0.101B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.098B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.086B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.073B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.072B | 0.00 |
| SEP Acquisition (SEPA) | United States | $0.059B | 0.00 |
| Hyperfine (HYPR) | United States | $0.059B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.056B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.056B | 113.33 |
| Vasomedical (VASO) | United States | $0.054B | 9.73 |
| Vicarious Surgical (RBOT) | United States | $0.050B | 0.00 |
| InspireMD (NSPR) | Israel | $0.046B | 0.00 |
| DarioHealth (DRIO) | United States | $0.043B | 0.00 |
| Aspira Women's Health (AWH) | United States | $0.042B | 0.00 |
| ReWalk Robotics (LFWD) | Israel | $0.042B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.039B | 0.00 |
| LENSAR (LNSR) | United States | $0.036B | 0.00 |
| Pixie Dust Technologies (PXDT) | Japan | $0.036B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.035B | 0.00 |
| Precision Optics (POCI) | United States | $0.034B | 0.00 |
| Spectral AI (MDAI) | United States | $0.032B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.023B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.021B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.021B | 0.00 |
| QT Imaging Holdings (QTI) | United States | $0.019B | 0.00 |
| PAVmed (PAVM) | United States | $0.017B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.017B | 0.00 |
| T2 Biosystems (TTOO) | United States | $0.015B | 0.00 |
| NexGel (NXGL) | United States | $0.014B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.013B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.013B | 0.00 |
| Avinger (AVGR) | United States | $0.006B | 0.00 |
| Venus Concept (VERO) | Canada | $0.005B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.004B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| Tenon Medical (TNON) | United States | $0.003B | 0.00 |
| Dynatronics (DYNT) | United States | $0.003B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.002B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| Nuwellis (NUWE) | United States | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.001B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |